Aleor Dermaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Testosterone Topical Solution USP, 30 mg per pump actuation, Alembic Pharmaceuticals said in a regulatory filing.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3vxqeN0
via IFTTT
0 comments:
Post a Comment